Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Record History view now displays an expanded sequence of past versions and release-note style entries, and the footer/navigation has been updated to include additional links and site information.SummaryDifference77%

- Check17 days agoChange DetectedThe latest version of the study history page removes the site footer and associated navigation/release-notes elements, resulting in a cleaner, more minimal layout.SummaryDifference17%

- Check24 days agoChange DetectedThe Record History view adds a Compare control and a Study Status section, and the revision list includes newer entries up to 2026-06-04, reflecting updated navigation and organization of study revisions.SummaryDifference44%

- Check38 days agoChange DetectedThe study record now shows that recruitment is no longer ongoing, impacting who can enroll. A new Revision: v3.6.0 has been added to the history, signaling an updated version of the record.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the Study Record History page. This reflects a routine platform/UI release associated with updating the page's history display.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry (v3.5.4) is added to the history, replacing the previous revision (v3.5.3). This indicates a software or UI update recorded in the page's version log and reflects an updated version of the history page itself.SummaryDifference0.1%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.